Trial Profile
Effects of Lisdexamfetamine on Bradyphrenia in Multiple Sclerosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 18 Sep 2022
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 15 Jun 2012 New trial record